Literature DB >> 7889284

Voltage- and time-dependent inhibitory effects on rat aortic and porcine coronary artery contraction induced by propafenone and quinidine.

F Pérez-Vizcaíno1, B Fernández del Pozo, F Zaragozá, J Tamargo.   

Abstract

1. Class I antiarrhythmic drugs (e.g. Na+ channel blockers) such as propafenone and quinidine also inhibit voltage-gated Ca2+ and K+ channels. In the present paper the voltage- and time-dependent inhibitory effects of propafenone and quinidine were studied on depolarization-induced vascular contractions and 45Ca2+ uptake in isolated endothelium denuded rat aorta and pig left descending coronary artery. 2. Quinidine and propafenone (10(-7) M -5 x 10(-5) M) produced a concentration-dependent relaxation of the contractions induced by 80 mM KCl. Propafenone was significantly more potent (P < 0.05) than quinidine in both rat aorta and pig coronary arteries but both drugs more potent (P < 0.05) in relaxing rat aorta than pig coronary arteries. In rat aortic rings, the relaxant effects of propafenone were unaffected by pretreatment with the Na+ channel blocker, tetrodotoxin. 3. The degree of inhibition produced after prolonged exposure (40 min) to propafenone and quinidine differed as the time of depolarization with 80 mM KCl was increased. Quinidine (3 x 10(-6) M, 10(-5) M and 3 x 10(-5) M) not only produced an inhibition at the very early stage of contraction, but also a time-dependent inhibition was observed. In contrast, propafenone (10(-6) M, 3 x 10(-6) M and 10(-5) M) produced a more marked concentration-dependent early block but only a mild time-dependent inhibition.4. The voltage-dependence of propafenone- and quinidine-induced inhibition, was studied in rat aorta and coronary arteries which had been incubated in 5 or 40mM KCl Ca2+-free solution and then contracted by changing the bath solution to 100 mM KCI and 2 mM CaCl2 solution. The inhibitor effects of quinidine were significantly enhanced (P <0.05) when the preparations were preincubated in 40 mMKCl (depolarizing) solution. In contrast, the effects of propafenone were quite similar in 5 or in 40 mMKCI solution.5. Quinidine, 10-5 M, produced a greater inhibition (P<0.05) of 100 mM KCl-stimulated 45Ca2+ uptake in aortic rings preincubated in depolarizing as compared to normal solution. In contrast, the inhibition produced by 3 x 10-6 M propafenone was similar in aortic rings incubated in 5 or 40 mM KCl solution.6.It is concluded that both quinidine and propafenone inhibited vascular smooth muscle contraction which could be attributed to reduced Ca2+ entry. The voltage- and time-dependent inhibitory effects of quinidine may reflect an increased binding of the drug to Ca2+ channels at depolarized potentials.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7889284      PMCID: PMC1510496          DOI: 10.1111/j.1476-5381.1994.tb17137.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  36 in total

1.  Inhibition of adrenergic vasoconstriction by quinidine.

Authors:  P G Schmid; L D Nelson; A L Mark; D D Heistad; F M Abboud
Journal:  J Pharmacol Exp Ther       Date:  1974-01       Impact factor: 4.030

Review 2.  Antiarrhythmic drug action. Blockade of the inward sodium current.

Authors:  A O Grant; C F Starmer; H C Strauss
Journal:  Circ Res       Date:  1984-10       Impact factor: 17.367

Review 3.  Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs.

Authors:  L M Hondeghem; B G Katzung
Journal:  Annu Rev Pharmacol Toxicol       Date:  1984       Impact factor: 13.820

Review 4.  Mechanisms of calcium antagonist-induced vasodilation.

Authors:  C Cauvin; R Loutzenhiser; C Van Breemen
Journal:  Annu Rev Pharmacol Toxicol       Date:  1983       Impact factor: 13.820

5.  Adverse hemodynamic effects of intravenous disopyramide compared with quinidine in conscious dogs.

Authors:  R A Walsh; L D Horwitz
Journal:  Circulation       Date:  1979-11       Impact factor: 29.690

6.  Quinidine is a competitive antagonist at alpha 1- and alpha 2-adrenergic receptors.

Authors:  H J Motulsky; A S Maisel; M D Snavely; P A Insel
Journal:  Circ Res       Date:  1984-09       Impact factor: 17.367

7.  Effect of propafenone on the membrane currents of rabbit sino-atrial node cells.

Authors:  H Satoh; K Hashimoto
Journal:  Eur J Pharmacol       Date:  1984-03-23       Impact factor: 4.432

8.  Effects of propafenone on calcium currents in single ventricular myocytes of guinea-pig.

Authors:  L Fei; J S Gill; W J McKenna; A J Camm
Journal:  Br J Pharmacol       Date:  1993-05       Impact factor: 8.739

9.  Clinical and electrophysiological effects of intravenous quinidine in man.

Authors:  D S Hirschfeld; C T Ueda; M Rowland; M M Scheinman
Journal:  Br Heart J       Date:  1977-03

10.  Interactions of organic calcium channel antagonists with calcium channels in single frog atrial cells.

Authors:  A Uehara; J R Hume
Journal:  J Gen Physiol       Date:  1985-05       Impact factor: 4.086

View more
  1 in total

1.  Stereoselective effects of the enantiomers, quinidine and quinine, on depolarization- and agonist-mediated responses in rat isolated aorta.

Authors:  B F del Pozo; F Pérez-Vizcaíno; E Villamor; F Zaragozá; J Tamargo
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.